Aug 28 |
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
Aug 27 |
FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL
|
Aug 26 |
BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?
|
Aug 26 |
Top 2 Health Care Stocks That May Plunge In August
|
Aug 26 |
BeiGene stock rises on FDA fast track tag for investigational cancer therapy
|
Aug 26 |
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
|
Aug 23 |
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
|
Aug 22 |
BeiGene: Poised For Re-Rating As BTKi Sales Show Strong Beat
|
Aug 22 |
High Growth Tech Stocks To Watch In August 2024
|
Aug 13 |
3 US Stocks That May Be Undervalued According To Estimates
|